BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 29342419)

  • 1. Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2.
    Nakamura M; Fujita K; Toyoda Y; Takada T; Hasegawa H; Ichida K
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):77-81. PubMed ID: 29342419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol.
    Stamp LK; Wallace M; Roberts RL; Frampton C; Miner JN; Merriman TR; Dalbeth N
    Drug Metab Pharmacokinet; 2018 Dec; 33(6):241-242. PubMed ID: 30274827
    [No Abstract]   [Full Text] [Related]  

  • 3. An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites.
    Pilon MO; Leclair G; Oussaïd E; St-Jean I; Jutras M; Gaulin MJ; Mongrain I; Busseuil D; Rouleau JL; Tardif JC; Dubé MP; de Denus S
    Clin Transl Sci; 2022 Aug; 15(8):2024-2034. PubMed ID: 35689378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration.
    Stamp LK; Chapman PT; Barclay M; Horne A; Frampton C; Merriman TR; Wright DFB; Drake J; Dalbeth N
    Clin Transl Sci; 2020 Jan; 13(1):110-115. PubMed ID: 31444839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCG2/BCRP dysfunction as a major cause of gout.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Suzuki H; Hosoya T; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1117-28. PubMed ID: 22132966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
    Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCG2 dysfunction increases the risk of renal overload hyperuricemia.
    Matsuo H; Takada T; Nakayama A; Shimizu T; Sakiyama M; Shimizu S; Chiba T; Nakashima H; Nakamura T; Takada Y; Sakurai Y; Hosoya T; Shinomiya N; Ichida K
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):266-74. PubMed ID: 24940678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCG2 as a therapeutic target candidate for gout.
    Fujita K; Ichida K
    Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of inhibition of xanthine oxidoreductase by allopurinol: crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinol.
    Okamoto K; Eger BT; Nishino T; Pai EF; Nishino T
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):888-93. PubMed ID: 18600558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ROLE OF SLC2A9 AND ABCG2 GENE POLYMORPHISMS IN ORIGIN OF HYPERURICEMIA AND GOUT].
    Fadieieva A; Prystupa L; Pogorelova O; Kirichenko N; Dudchenko I
    Georgian Med News; 2016 Mar; (252):79-83. PubMed ID: 27119840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
    Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K
    Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnic differences in ATP-binding cassette transporter, sub-family G, member 2 (ABCG2/BCRP): genotype combinations and estimated functions.
    Sakiyama M; Matsuo H; Takada Y; Nakamura T; Nakayama A; Takada T; Kitajiri S; Wakai K; Suzuki H; Shinomiya N
    Drug Metab Pharmacokinet; 2014; 29(6):490-2. PubMed ID: 24869748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.
    Ernst ME; Fravel MA
    Clin Ther; 2009 Nov; 31(11):2503-18. PubMed ID: 20109996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-Wide Association and Functional Studies Reveal Novel Pharmacological Mechanisms for Allopurinol.
    Brackman DJ; Yee SW; Enogieru OJ; Shaffer C; Ranatunga D; Denny JC; Wei WQ; Kamatani Y; Kubo M; Roden DM; Jorgenson E; Giacomini KM
    Clin Pharmacol Ther; 2019 Sep; 106(3):623-631. PubMed ID: 30924126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion.
    Hoque KM; Dixon EE; Lewis RM; Allan J; Gamble GD; Phipps-Green AJ; Halperin Kuhns VL; Horne AM; Stamp LK; Merriman TR; Dalbeth N; Woodward OM
    Nat Commun; 2020 Jun; 11(1):2767. PubMed ID: 32488095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of ABCG2 dysfunction as a major factor contributing to gout.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Takada Y; Okada C; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1098-104. PubMed ID: 22132963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol].
    Ohno I; Okabe H; Yamaguchi Y; Saikawa H; Uetake D; Hikita M; Gomi H; Ichida K; Hosoya T
    Nihon Jinzo Gakkai Shi; 2008; 50(4):506-12. PubMed ID: 18546882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Characterization of Clinically-Relevant Rare Variants in
    Toyoda Y; Mančíková A; Krylov V; Morimoto K; Pavelcová K; Bohatá J; Pavelka K; Pavlíková M; Suzuki H; Matsuo H; Takada T; Stiburkova B
    Cells; 2019 Apr; 8(4):. PubMed ID: 31003562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of BOF-4272 on the oxidation of allopurinol and pyrazinamide in vivo. Is xanthine dehydrogenase or aldehyde oxidase more important in oxidizing both allopurinol and pyrazinamide?
    Yamamoto T; Moriwaki Y; Suda M; Nasako Y; Takahashi S; Hiroishi K; Nakano T; Hada T; Higashino K
    Biochem Pharmacol; 1993 Dec; 46(12):2277-84. PubMed ID: 8274161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.